
A study of 595 liver transplant donor-recipient pairs found that genetic variants, especially donor PNPLA3 rs738409-G, impact post-transplant steatotic liver disease (SLD). Despite genetic influences, adding polygenic risk scores (PRS-5) to non-genetic risk models only slightly improved prediction. This highlights the role of modifiable factors in managing post-LT SLD risk.
Like
Save
Share